PYC Therapeutics (Australia) Performance

PYC Stock   1.40  0.05  3.45%   
The company owns a Beta (Systematic Risk) of -0.18, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PYC Therapeutics are expected to decrease at a much lower rate. During the bear market, PYC Therapeutics is likely to outperform the market. At this point, PYC Therapeutics has a negative expected return of -0.32%. Please make sure to check PYC Therapeutics' coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if PYC Therapeutics performance from the past will be repeated at future time.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor
1:10
Last Split Date
2024-11-15
1
Insider Stock Buying Of PYC Therapeutics Delivers Return On AU5.25m Investment - Yahoo Finance
10/28/2024
2
PYC Therapeutics Announces Security Consolidation Plan - MSN
11/20/2024
3
PYC Therapeutics Announces Share Consolidation Impact - TipRanks
11/26/2024
Begin Period Cash Flow15.6 M
  

PYC Therapeutics Relative Risk vs. Return Landscape

If you would invest  180.00  in PYC Therapeutics on September 26, 2024 and sell it today you would lose (40.00) from holding PYC Therapeutics or give up 22.22% of portfolio value over 90 days. PYC Therapeutics is producing return of less than zero assuming 3.8399% volatility of returns over the 90 days investment horizon. Simply put, 34% of all stocks have less volatile historical return distribution than PYC Therapeutics, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon PYC Therapeutics is expected to under-perform the market. In addition to that, the company is 4.74 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.06 per unit of volatility.

PYC Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for PYC Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PYC Therapeutics, and traders can use it to determine the average amount a PYC Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.083

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPYC

Estimated Market Risk

 3.84
  actual daily
34
66% of assets are more volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average PYC Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PYC Therapeutics by adding PYC Therapeutics to a well-diversified portfolio.

PYC Therapeutics Fundamentals Growth

PYC Stock prices reflect investors' perceptions of the future prospects and financial health of PYC Therapeutics, and PYC Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PYC Stock performance.

About PYC Therapeutics Performance

Assessing PYC Therapeutics' fundamental ratios provides investors with valuable insights into PYC Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the PYC Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
PYC Therapeutics is entity of Australia. It is traded as Stock on AU exchange.

Things to note about PYC Therapeutics performance evaluation

Checking the ongoing alerts about PYC Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PYC Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PYC Therapeutics generated a negative expected return over the last 90 days
PYC Therapeutics may become a speculative penny stock
PYC Therapeutics has high historical volatility and very poor performance
PYC Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 22.06 M. Net Loss for the year was (37.73 M) with profit before overhead, payroll, taxes, and interest of 15.81 M.
PYC Therapeutics has accumulated about 15.57 M in cash with (38.59 M) of positive cash flow from operations.
Roughly 59.0% of the company outstanding shares are owned by corporate insiders
Evaluating PYC Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate PYC Therapeutics' stock performance include:
  • Analyzing PYC Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PYC Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining PYC Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating PYC Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of PYC Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of PYC Therapeutics' stock. These opinions can provide insight into PYC Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating PYC Therapeutics' stock performance is not an exact science, and many factors can impact PYC Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for PYC Stock Analysis

When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.